| Date Filed | Type | Description |
| 10/05/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,589 shares
@ $1.27, valued at
$4.6k
|
|
| 08/08/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,722 shares
@ $1.72, valued at
$6.4k
|
|
| 07/06/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,538 shares
@ $1.72, valued at
$6.1k
|
|
| 06/07/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,536 shares
@ $2.2404, valued at
$7.9k
|
|
| 05/05/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,805 shares
@ $3.3516, valued at
$12.8k
|
|
| 04/05/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,497 shares
@ $3.97, valued at
$13.9k
|
|
| 04/05/2023 |
3
| Paulson Richard A. (Director) has filed a Form 3 on bluebird bio, Inc. |
| 04/05/2023 |
4
| Paulson Richard A. (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 4,663 shares
@ $0
Granted 7,500 options to buy
@ $3.3, valued at
$24.8k
|
|
| 03/07/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,506 shares
@ $3.16, valued at
$11.1k
|
|
| 03/02/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 252,000 shares
@ $0
Sold 33,033 shares
@ $3.0292, valued at
$100.1k
|
|
| 02/08/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,922 shares
@ $3.27, valued at
$12.8k
|
|
| 12/06/2022 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,490 shares
@ $5.17, valued at
$18k
|
|
| 11/08/2022 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,493 shares
@ $4.54, valued at
$15.9k
|
|
| 10/05/2022 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Sold 3,488 shares
@ $5.87, valued at
$20.5k
|
|
| 09/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Paulson Richard A. (President and CEO) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 373,200 shares
@ $0
Granted 559,800 options to buy
@ $9.44, valued at
$5.3M
|
|
| 05/26/2020 |
4
| Paulson Richard A. (Director) has filed a Form 4 on Karyopharm Therapeutics Inc.|
Txns:
| Granted 16,400 options to buy
@ $19.11, valued at
$313.4k
|
|
| 03/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |